canadian academic detailing collaboration - cadth.ca · pdf file4 canadian academic detailing...
TRANSCRIPT
Canadian Academic Detailing Collaboration
Michael Allen MDDalhousie University CME
CCOHTA Invitational SymposiumApril 3 – 4, 2006
Tuesday 1030-1200Session 10
2
Outline
Definition
Development
Academic detailing programs
Projects
Next steps
3
Definition
One-on-one educational intervention provided to physicians in their office by a trained health care professional
Evidence-based
Information for clinical decision-making
4
Canadian Academic Detailing Collaboration - Development
British Columbia – 1993 Saskatchewan – 1997Nova Scotia and Alberta – 2001Facilitated poster session – 2002 Manitoba – 2003University of Victoria School of Health Information Science – 2003 Links with CADTH/COMPUS
6
Canadian Academic Detailing Collaboration – Programs
British ColumbiaBC Community Drug Utilization Program50-60 family physicians in North/West Vancouver
AlbertaDrug Utilization Program of Alberta100 rural physicians - David Thompson Health Region 150 urban physicians – Calgary Health Region
SaskatchewanRx Files Academic Detailing Program400 physicians and other HCPs in SK
7
Canadian Academic Detailing Collaboration – Programs
ManitobaPrescription Information Service of ManitobaGeneral practitioners – 1240Pharmacists – 1450
Nova ScotiaDalhousie CME Academic Detailing Service350 physicians and other HCPs in Nova Scotia
newsletter
8
Process and Outcome Evaluation of Academic Detailing in 5 Provinces
Canadian Academic Detailing Collaboration - Projects
Best Practices Contribution Program
9
1. Evaluation of ADing in North/West Vancouver – BC2. Effects of ADing on prescribing – U Victoria3. Canadian and international experiences with ADing 4. Evaluate printed educational materials – AB5. Time and motion study – SK6. Outcomes evaluation (READ study) – MB7. Physicians’ perceptions of ADing – NS
Canadian Academic Detailing Collaboration - Projects
10
CADC Projects - British ColumbiaAssessment of Academic Detailing in North/West Vancouver
80 physicians randomized to get ADing session on CHF or another drug topic
After 6 months arms crossed over
Preliminary BC Pharmacare data show changes in prescribing of heart failure medications in group receiving academic detailing
11
CADC Projects- British ColumbiaAssessment of Academic Detailing in North/West Vancouver
Now analyzing the following BC databases to determine effect of ADing
Drugs (PharmaNet)Physician billing (MSP)Hospitalization (DAD)
Methods in upcoming Basic and Clinical Pharmacology and ToxicologyWill refine this method to assess academic detailing in other provinces
12
CADC Projects- British ColumbiaAssessment of Academic Detailing in North/West Vancouver
Anne Nguyen
13
Randomize paired towns and practice
addresses Average Delay = 1-3 mo
Early visits
Delayed visits
CADC Projects - University Victoria Randomized delayed control trial
New patients
prescribed target drugs
TimeEarly visit
Delayed visit
Immediate Impact: Change in prescribing after visit to early physician, compared to matching delayed
physician, prior to the delayed visit
Window
Early
Delayed
15
Malcolm Maclure
CADC Projects - University Victoria Randomized delayed control trial
16
CADC ProjectsSynthesis of academic detailing best practices
5 Canadian programs and 10 international programs interviewed Best practices and innovative approaches to:
Selecting successful topics Physician incentives to participate and be influenced by prescribing recommendationsEffective printed educational materialsCharacteristics of a good academic detailer and a good visitComplementary strategiesEvaluation methods
17
CADC ProjectsSynthesis of academic detailing best practices
Programs similar goal to improve prescribing and medication use but differ in
Types of visitsEducational materials usedComplementary strategies.
Most AD activities are part of larger programs using a variety of initiatives and interventions Programs refine activities based on
Program objectivesPreferences of their target audienceHealth system, length of operation, and funding
19
CADC Projects – AlbertaEvaluation of printed educational materials
Collected PEMs from programs consulted during international synthesis Developed classification for PEMs
Key messages – post cardDecision aid – one page summaryDecision oriented evidence – 2 to 5 pagesOriginal reports – reprints of papers, CPGs
20
CADC Projects – AlbertaEvaluation of printed educational materials
Involved information design specialists – U of AlbertaDeveloped performance specifications for PEMs – used COPD materialDeveloped design criteriaEvaluated PEMs from each program and made suggestions.
21
Contact Information
Harold Lopatka, Program DirectorEmail: [email protected]: 780-492-0110Website: www.uofaweb.ualberta.caAddress: Alberta Drug Utilization Program, University of Alberta, 305 Campus Tower, 8625 – 112 Street, Edmonton, AB, T6G 1K8
22
CADC Projects - SaskatchewanTime and motion
Data collection to include:Time for research & material preparationTime for academic detailing
BookingDrivingWaitingDiscussing
Type of visit (individual vs group)Kilometres travelled
23
CADC Projects - SaskatchewanTime and motion
Academic Detailing VisitsNumber of prescribers / visit: 1.2BC - 2.4 SK
Time discussing topic in MD office (minutes): BC: 21; AB: 32; SK: 39; NS: 33Individual sessions shorter: Ave 17min SK
Time traveling:24-59 min depending on region covered e.g. rural
Total time for visit: (includes booking visits, follow-up)varied from 60-94 min/visit
24
CADC Projects - SaskatchewanTime and motion
Time for research & material preparation80 hrs – 975 hrs depending on topic and depth of analysis
Time for detailer trainingVaried from 49-58 hrs/detailer/topic
Total Cost - depends on …Type/depth of topic; controversial issues, etc.Number/type of detailers; geographical issuesRange: $278-389/visit; $115-316/prescriber
26
CADC Projects – ManitobaOutcome evaluation
Rural Evaluation of Academic Detailing (READ) Study
Objectives:Determine cost-effectiveness and effect on prescribing of academic detailing and printed education material
Methodology:Cluster stratified RCT60 GP from 20 clinics in 2 rural health auth.
27
CADC Projects – ManitobaOutcome evaluation
READ study (continued)Two-arm intervention 30 FPs per arm
Printed material + academic detailing on CHFPrinted material on separate topic - control
OutcomesPrescribing of beta-blockers in CHF
Completed
28
CADC Projects – ManitobaOutcome evaluation
READ QuestionnaireBased on Theory of Planned Behaviour
Beta-blocker use in CHFStopping benzodiazepines in patients on long-term therapyManaging insomnia without prescribing benzodiazepines
29
CADC Projects – ManitobaOutcome evaluation
SubjectiveNorms
Attitudes
Intention Behaviour
Perceived Behavioural
Control
30
CADC Projects – ManitobaOutcome evaluation
Questionnaire information used to adapt intervention materials to behavioural targets
Prescribing Beta-Blockers in CHFdifficult - provide detailed titration information and case studies to make prescribing easierrisky - safety issues addressed; prevention, monitoring and resolution of side effects
32
CADC Projects – Nova ScotiaPhysicians’ perceptions of academic detailing
Questionnaire and interviews with doctors who have and have not used academic detailingQuestionnaire Mailed Received %
Not used 408 60 15Have used 481 219 46Total 879 288 33
33
CADC Projects – Nova ScotiaPhysicians’ perceptions of academic detailing
Encourage use Evidence-based approach
Topics useful to practice
Useful handout material
Discourage useSpending office time doing CME
Scheduling time to see detailer
CME provided by non-MD
34
CADC Projects – Nova ScotiaPhysicians’ perceptions of academic detailing
Michael Allen
35
CADC Collaboration on developing content
Canadian and US updates on prevention of cardiovascular diseaseCritical appraisal of original literatureTeleconferences using voice over internet and and document sharing with Elluminate
Mowafa Househ - [email protected]
36
CADC Collaboration on developing content
Each has taken responsibility for different aspects of the topic
MenWomenElderlyPeople with diabetes
Working on common messages and some common handout material
AtorvastatinCARDS
74(40-483)
Atorvastatin CARDS ASCOT-LLA**Diabetics
PravastatinPROSPERPravastatinPROSPERElderly (≥ 65 years old)
LovastatinAFCAPS/TexCAPSLovastatinAFCAPS/TexCAPSAtorvastatinASCOT
All women
PravastatinWOSCOPSLovastatinAFCAPS/TexCAPSAtorvastatinASCOT-LLA
45(35-64)
PravastatinWOSCOPSLovastatinAFCAPS/TexCAPS*AtorvastatinASCOT-LLA
All men
Primary Prevention
Simvastatin4S26(19-44)
PravastatinLIPID**SimvastatinHPS 4S
Diabetics
19(12-40)
Simvastatin4SPravastatinCARE
26(21-34)
PravastatinCARE, LIPID, PROSPERSimvastatin4S, HPS
Elderly (≥ 65 years old)
PravastatinLIPIDSimvastatin4S
33(24-55)
PravastatinCARE, LIPID**Simvastatin4S, HPS
All women
42(33-60)
PravastatinLIPID*Simvastatin4S, HPS*
27(22-33)
PravastatinLIPID, CARE*Simvastatin4S, HPS
All men
NNT for5 years(95% CIs)
Drugs and trialsNNT for5 years(95% CIs)
Drugs and trialsSecondary Prevention
All Cause MortalityMajor Cardiac EventsNon- fatal MI, deaths from CHD
Evidence for benefit
Insufficient evidence
Major cardiac events All cause mortality
Men
Men
Women
Women
Elderly
Elderly
Diabetes
Diabetes
Secondary
Primary
38
Collaboration on Academic DetailingProcess evaluation of the CADC
Interviews with participantsSuccesses - the level of cooperation and implementation of several evaluation projectsChallenges - how to collaborate efficiently, how to reconcile local and national prioritiesBenefits of collaboration expected to grow over time. Requires effort and resources.\Developing partnership with COMPUS is a key priority.
39
Collaboration on Academic DetailingProcess evaluation of the CADC
ActivitiesRegular communication
Education and training
Advocacy
Partnering
Research and evaluation
Outcomes
Quality improvement
Proposal developed
Expected to follow from report and partnering
Growing partnership with COMPUS, e.g., toolkit
Insights/ capacity-building from 2-yr program
40
Collaboration on Academic DetailingProcess evaluation of the CADC
Richard Morrow
41
Next steps
Life without AlbertaReview all projectsDetermine relevance for our programsDevelop strategic planContinue to build relationship with COMPUS/CADTH